6,7-disubstituted-2-aminotetralines active as immunomodulators a

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31225

Patent

active

059625252

ABSTRACT:
6,7-disubstituted-2-aminotetralines of general formula (1) ##STR1## and their pharmacologically acceptable salts, wherein X and Y, identical or different are selected from the group consisting of methoxy, acetoxy and fluoro; and R and R.sub.1, identical or different, are selected from the group consisting of hydrogen, ethyl, propyl, cyclopropylmethyl, 2-hydroxy-2-phenylethyl, 2-hydroxy-2-(4-methylphenyl)ethyl and 2-hydroxy-3-(4-methoxyphenoxy)propyl are endowed with immunomodulator activity.

REFERENCES:
patent: 4593042 (1986-06-01), Liang
Atwal et al. "Substituted 1,2,3,4-tetrahydroaminonaphthol Anti-Hypertensive Agents, Calcium Channel Blockers and Adrenergic Receptor Blockers with Catecholamine-depleting Effects" J. Med. chem. 30:627-635, 1987.
Ertel et al. "Immunoprotective Effect of Calcium Channel Blocker on Macrophage Antigen Presentation function, Major Histocompatability class II Antigen . . . " Surgery 108:154-160, 1990.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

6,7-disubstituted-2-aminotetralines active as immunomodulators a does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 6,7-disubstituted-2-aminotetralines active as immunomodulators a, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6,7-disubstituted-2-aminotetralines active as immunomodulators a will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1172177

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.